Influence of 17-Hydroxyprogesterone, Progesterone and Sex Steroids on Mineralocorticoid Receptor Transactivation in Congenital Adrenal Hyperplasia
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency leads to accumulation of steroid precursors and adrenal androgens. These steroids may have a biological effect on the steroid receptor with clinical consequences on diagnostics and treatment in CAH patients. Therefore, we analysed the effect of accumulated steroids [17-hydroxyprogesterone (17OHP), progesterone, androstenedione and testosterone] on aldosterone-mediated transactivation of the human mineralocorticoid receptor (hMR). METHODS: A transactivation assay using transiently transfected COS7 cells was employed. Cells were co-transfected with hMR-cDNA, MMTV-luciferase and renilla-luciferase expression vectors. Transfected cells were incubated with six different steroid concentrations in addition to aldosterone (10-10M). Luciferase and renilla activities were measured to quantify hMR transactivation. RESULTS: Linear regression analysis showed statistically significant linear inhibition of transactivation of the hMR by 10-10M aldosterone in the presence of increasing 17OHP [F(1,5) = 11.34, p = 0.019] and progesterone [F(1,5) = 11.08, p = 0.021] concentrations. In contrast, neither androstenedione nor testosterone affected hMR transactivation by aldosterone at a concentration of 10-10M. CONCLUSION: Our study shows for the first time that neither androstenedione nor testosterone has a biological effect on aldosterone-mediated transactivation of the hMR. 17OHP and progesterone have an anti-mineralocorticoid effect in vitro that may clinically lead to an increased requirement of mineralocorticoids in poorly controlled CAH patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“By contrast, 17OHP and progesterone inhibit aldosterone-mediated transactivation of the mineralocorticoid receptor in a dose-dependent fashion, explaining the strong antimineralocorticoid effect of 17OHP and progesterone in vitro (139,140).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
Geller, D. S., Farhi, A., Pinkerton, N., Fradley, M., Moritz, M., Spitzer, A., Meinke, G., Tsai, F. T. F., Sigler, P. B., & Lifton, R. P. (2000) · Science · doi:10.1126/science.289.5476.119 · Cited by 675
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Self-citationThe Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological Biology
Viengchareun, S., Le Menuet, D., Martinerie, L., Munier, M., Tallec, L. P.-L., & Lombès, M. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05012 · Cited by 316
Rupprecht, R., Reul, J. M. H. M., van Steensel, B., Spengler, D., Söder, M., Berning, B., Holsboer, F., & Damm, K. (1993) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(93)90072-h · Cited by 298
Fejes-Tóth, G., Pearce, D., & Náray-Fejes-Tóth, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2973 · Cited by 246
A Common Polymorphism in the Mineralocorticoid Receptor Modulates Stress Responsiveness
DeRijk, R. H., Wüst, S., Meijer, O. C., Zennaro, M.-C., Federenko, I. S., Hellhammer, D. H., Giacchetti, G., Vreugdenhil, E., Zitman, F. G., & de Kloet, E. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0915 · Cited by 214
Grossmann, C., Scholz, T., Rochel, M., Bumke-Vogt, C., Oelkers, W., Pfeiffer, A., Diederich, S., & Bahr, V (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510397 · Cited by 212
Rupprecht, R. (1993) · Molecular Endocrinology · doi:10.1210/me.7.4.597 · Cited by 206
THE METABOLIC EFFECTS OF PROGESTERONE IN MAN*†
LANDAU, R. L., BERGENSTAL, D. M., LUGIBIHL, K., & KASCHT, M. (1955) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-15-10-1194 · Cited by 189
Lombès, M., Farman, N., Oblin, M. E., Baulieu, E. E., Bonvalet, J. P., Erlanger, B. F., & Gasc, J. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1086 · Cited by 134
Strott, C. A., Yoshimi, T., & Lipsett, M. B. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106052 · Cited by 132
Quinkler, M., Meyer, B., Bumke-Vogt, C., Grossmann, C., Gruber, U., Oelkers, W., Diederich, S., & Bahr, V (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460789 · Cited by 130
Odermatt, A., Arnold, P., & Frey, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100374200 · Cited by 129
Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Reisch, N., Arlt, W., & Krone, N. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327794 · Cited by 106
Self-citationKROZOWSKI, Z. S., RUNDLE, S. E., WALLACE, C., CASTELL, M. J., SHEN, J.-H., DOWLING, J., FUNDER, J. W., & SMITH, A. I. (1989) · Endocrinology · doi:10.1210/endo-125-1-192 · Cited by 101
Lippe, B. M., LAFRANCHI, S. H., Lavin, N., Parlow, A. F., Coyotupa, J., & Kaplan, S. A. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80340-9 · Cited by 98
Mooij, C. F., Kroese, J. M., Claahsen‐van der Grinten, H. L., Tack, C. J., & Hermus, A. R. M. M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03690.x · Cited by 92
Self-citationWAMBACH, G., & HIGGINS, J. R. (1978) · Endocrinology · doi:10.1210/endo-102-6-1686 · Cited by 88
Mechanistic aspects of mineralocorticoid receptor activation
Hellal-Levy, C., Fagart, J., Souque, A., & Rafestin-Oblin, M.-E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00958.x · Cited by 78
Sasano, H., Fukushima, K., Sasaki, I., Matsuno, S., Nagura, H., & Krozowski, Z. S. (1992) · Journal of Endocrinology · doi:10.1677/joe.0.1320305 · Cited by 69
Riepe, F. G., Finkeldei, J., SANCTIS, L. D., Einaudi, S., Testa, A., Karges, B., Peter, M., Viemann, M., Grötzinger, J., Sippell, W. G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1161 · Cited by 69
Self-citationFrisch, H., Parth, K., Schober, E., & Swoboda, W. (1981) · Archives of Disease in Childhood · doi:10.1136/adc.56.3.208 · Cited by 56
Mooij, C. F., Kroese, J. M., Sweep, F. C. G. J., Hermus, A. R. M. M., & Tack, C. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024204 · Cited by 42
Self-citationMartínez, F., Mansego, M. L., Martín-Escudero, J. C., Redón, J., & Chaves, F. J. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.39 · Cited by 34
INTERACTION OF SYNTHETIC PROGESTAGENS WITH RENAL MINERALOCORTICOID RECEPTORS
Wambach, G., Higgins, J. R., Kern, D. C., & Kaufmann, W. (1979) · Acta Endocrinologica · doi:10.1530/acta.0.0920560 · Cited by 31
Evidence for the Secretion of an Antimineralocorticoid in Congenital Adrenal Hyperplasia*
KUHNLE, U., LAND, M., & ULICK, S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-934 · Cited by 29
Auzou, G., Fagart, J., Souque, A., Hellal-Lévy, C., Wurtz, J., Moras, D., & Rafestin-Oblin, M. E. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.684 · Cited by 29
Butkus, A., Congiu, M. A., Scoggins, B. A., & Coghlan, J. P. (1982) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1982.tb00792.x · Cited by 20
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationCongenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
“It shows very weak agonism with the glucocorticoid receptor (GR) (17) and antagonism with the mineralocorticoid receptor (MR) (18).”
BackgroundManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
46,XX DSD: Developmental, Clinical and Genetic Aspects
Alkhzouz, C., Bucerzan, S., Miclaus, M., Mirea, A.-M., & Miclea, D. (2021) · Diagnostics · doi:10.3390/diagnostics11081379 · Cited by 58
“Excess hydroxyprogesterone, in the case of untreated 21-hydroxylase deficiency, has an antimineralocorticoid effect; this effect is more obvious in the case of severe and improperly treated patients [60].”
Background
Metadata
- Authors
- Mooij, C. F., Parajes, S., Pijnenburg-Kleizen, K. J., Arlt, W., Krone, N., & Claahsen-van der Grinten, H. L.
- Affiliations
- Radboud University Medical Center (NL)
- University of Birmingham (GB)
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 83
- Issue
- 6
- Pages
- 414-421
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2019020433
- Cited by
- 27
- References
- 31
- Citations by year
- 2026: 3 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 3 · 2017: 2 · 2016: 1 · 2015: 2
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- European Commission (255424)
- ZonMw
- Xunta de Galicia
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, mineralocorticoid receptor, 17-hydroxyprogesterone, progesterone, androstenedione, testosterone, sex steroids
- MeSH terms
- Adrenal Hyperplasia, Congenital, Aldosterone, Androstenedione, Animals, Chlorocebus aethiops, Humans, Progesterone, Testosterone, Transcriptional Activation, Receptors, Mineralocorticoid, 17-alpha-Hydroxyprogesterone, COS Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.